Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Shareholders
Mar. 12, 2025 7:59 AM ETCTT Pharmaceutical Holdings, Inc. (CTTH)
TAMPA, FL / ACCESS Newswire / March 12, 2025 / CTT Pharmaceutical Holdings, Inc. (CTTH)
Dear Shareholders,
I wanted to issue this brief letter to share a few updates. To start, it's important to note that there are no delays with the NIH or NSF grants. These grants were filed in advance of the January 6th deadline and as a result we are expecting answers in May possibly April. I also received notification that the review process for these grants will start in March. The NIH grant would allow Johns Hopkins University the ability to move forward with clinical trials of our smoke-free low dose dissolvable strip and allow CTT to create the first oral smoking cessation product in 40 years. Additionally, we added two people to the company to help with the NIH and NSF grants. They have extensive knowledge about our technology and have many years of experience with grants.
CTT Pharma Uplists to the OTCQB Today
Mar. 09, 2025 6:00 PM ETCTT Pharmaceutical Holdings, Inc. (CTTH)
TAMPA, FL / ACCESS Newswire / March 9, 2025 / CTT Pharmaceutical Holdings, Inc. (CTTH) has entered the OTCQB Market today under the ticker symbol "CTTH". CTT Pharma's CEO will issue a news release to shareholders this Wednesday March 12, 2025.
Announces Uplisting to OTCQB Market Trading
Mar. 05, 2025 7:15 AM ETCTT Pharmaceutical Holdings, Inc. (CTTH)
TAMPA, FL / ACCESS Newswire / March 5, 2025 / CTT Pharmaceutical Holdings, Inc. (CTTH) is pleased to announce the OTC Markets Group has approved the trading of its common shares on the OTCQB Market. The company's common shares will trade on the OTCQB under the symbol "CTTH" as of the opening of the market on March 10, 2025. Uplisting to the OTCQB should provide CTT with greater liquidity and a more seamless trading experience for U.S. shareholders. The OTCQB is a premier marketplace for Pharmaceutical companies in early stage that are moving towards development of new technology. Companies listed on the OTCQB are current in their reporting and undergo yearly PCAOB Audits. CTT will make a formal announcement on March 10, 2025 announcing the uplisting to the OTCQB investor community. The CEO of CTT Pharma will issue a news release to shareholders on March 12, 2025.
Based on previous press releases, $CTTH should be hearing about the 3 grant they have applied for, the largest being a $15 million NIH grant for human studies with Johns Hopkins University for their Nicotine Strips for smoke cessation by the end of March. Between all three grants it could total close to $20 million. These are grants no need for debt or dilution, plus the CEO keeps buying shares in the open market.
#Nicotine
CTT Pharma Gives Uplisting Update
Press Release | 03/03/2025
TAMPA, FLORIDA / ACCESS Newswire / March 3, 2025 / CTT Pharmaceutical Holdings, Inc. (OTC PINK:CTTH) is expecting notification this week for uplisting status to the OTCQB. CTT will notify shareholders as more news becomes available.
CTT Pharmaceutical Holdings, Inc
@CTT_Pharma
·
2h
The OTC indicated to CTT Pharma that we will be getting more information about our uplisting to the OTCQB by early next week. CTT also found out this week that our NIH and NSF grants are not delayed.
CTTH=Keep in mind that they have under 57 million outstanding shares and only just over 23 million float.
CTTH = this company is moving fast toward a deal or at least getting grant money.imo
Feb. 03, 2025 7:15 AM ETCTT Pharmaceutical Holdings, Inc. (CTTH)
TAMPA, FL / ACCESS Newswire / February 3, 2025 / CTT Pharmaceuticals Holdings, Inc. (OTC:CTTH) is pleased to announce a reduction in its authorized share count by 150 million shares. CTT reduced the authorized share count from 300 million shares to 150 million shares. This change has already been filed with Delaware Division of Corporations. Furthermore, CTT's stock issuer has been notified and made the necessary corrections to reflect this change. This latest adjustment demonstrates CTT Pharma's ongoing commitment to optimizing its capital structure and delivering long-term value to shareholders. CTT is also in the process of gaining approval to uplist to the OTCQB and believes this decision benefits existing and future shareholders.
seeing some real volume- my interest is piqued for the news! $CTTH
OTC Disclosure & News Service
CTT Pharma will issue a news release January 22, 2025
$15,000,000 would be a lot for this company to work with.
CTTH -
CTT Pharmaceutical Holdings, Inc
@CTT_Pharma
·
40m
CTT Pharma will update shareholders January 7, 2025 on partnership with Johns Hopkins University.
CTTH
The CEO of CTT Pharma will be a presenter today for a smoking cessation meeting at the FDA Headquarters in Silver Springs, Maryland. CTT will be speaking in front of the FDA, NIH and many other people looking for new innovative ways to help smokers stop. pic.twitter.com/2690QKKikI
— CTT Pharmaceutical Holdings, Inc (@CTT_Pharma) October 21, 2024
is the ceo buying up shares just for the fun of it?
if your selling under a dollar you're not paying attention.
keep in mind that they have sold product a few years ago with aurora cannabis.so the trial is not to test if it works but if people like the method.
Not many will to sell so cheap, better days ahead.
me too from the beginning = finally
It’s nice news for sure.
Will this finally move with news?
I played this stock years ago when it went above 0.70.
They have a good product just don’t know how to promote it.
Followers
|
53
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1701
|
Created
|
10/30/06
|
Type
|
Free
|
Moderators |
Volume: | 6,606 |
Day Range: | 0.049 - 0.053 |
Last Trade Time: | 12:34:04 PM EDT |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |